Condition: Cancer T1-N0 or T2-N0 of the Oral Cavity · Sponsor: University Hospital, Montpellier
This is a single-center pilot study of open-label, non-randomized interventional research based on the outpatient management of 30 patients with T1-N0 or T2-N0 cancer in the oral cavity or oropharynx.
This description comes directly from the study's public registry record.
Renaud GARREL, ENT · +33 467-336-920 · r-garrel@chu-montpellier.fr
César CARTIER, ENT · +33 467-336-920 · c-cartier@chu-montpellier.fr
Always discuss trial participation with your own doctor first.
| Gui de Chauliac Hospital, ENT Department 80 rue Augustin Fliche | Montpellier, Hérault, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03545256